Âé¶¹´«Ã½

    Advertisement
    Belfast Telegraph12:40Dublin County Dublin England
    Korea Biomedical Review00:20Gilead Sciences Cancer Treatment Cancer
    Korea Biomedical Review20:36Gilead Sciences Cancer Treatment Cancer
    ecancer09:55T-Cells
    Drug Target Review03:35T-Cells
    Manufacturing Chemist03:04Leukaemia European Commission Pharma
    BioSpectrum Asia14:35Cancer Treatment Singapore Cancer
    Yesterday
    Korea Biomedical Review00:20 13-Aug-25
    In the last 7 days
    PR Newswire (Press Release)08:06 12-Aug-25
    FiercePharma11:51 8-Aug-25
    PR Newswire (Press Release)09:21 8-Aug-25
    HealthDay06:33 8-Aug-25
    Armagh I04:29 8-Aug-25
    Nature.com19:13 7-Aug-25
    The Irish News12:41 7-Aug-25
    Belfast Telegraph12:40 7-Aug-25
    In the last month
    PR Newswire (Press Release)07:05 5-Aug-25
    Korea Biomedical Review20:36 4-Aug-25
    Armagh I10:17 4-Aug-25
    PR Newswire (Press Release)06:10 4-Aug-25
    Manufacturing Chemist03:04 1-Aug-25
    Business Wire (Press Release)10:05 31-Jul-25
    ecancer09:55 31-Jul-25
    Nature.com07:05 30-Jul-25
    Clinical Trials Arena06:08 30-Jul-25
    Business Wire (Press Release)09:07 29-Jul-25
    Pharmafile07:51 29-Jul-25
    Business Wire (Press Release)02:00 29-Jul-25
    Drug Target Review03:35 28-Jul-25
    PR Newswire (Press Release)19:40 27-Jul-25
    BioSpectrum Asia14:35 27-Jul-25
    Korea Biomedical Review01:35 25-Jul-25
    STAT06:36 23-Jul-25
    ecancer11:20 22-Jul-25
    Business Wire (Press Release)09:10 22-Jul-25
    Korea Biomedical Review02:07 21-Jul-25
    Technology Networks09:23 17-Jul-25
    Business Wire (Press Release)08:07 17-Jul-25
    The Daily Pennsylvanian22:10 16-Jul-25
    Drug Target Review03:38 16-Jul-25
    ecancer11:06 15-Jul-25
    ecancer10:56 15-Jul-25
    Labiotech09:05 15-Jul-25
    British Society for Haematology04:34 15-Jul-25
    view more headlines
    13 Aug 00:20

    About our CAR-T news

    Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.